Summary
Danaher Corporation's Q2 2007 report shows robust sales growth, driven by strategic acquisitions and organic expansion across its segments, particularly Medical Technologies and Professional Instrumentation. The company reported a significant increase in net earnings and earnings per share compared to the prior year quarter, reflecting strong operational performance and successful integration of acquired businesses. Despite increased interest expenses due to financing for acquisitions, Danaher's financial health remains strong, supported by healthy operating cash flow and a solid balance sheet. The company continues to prioritize shareholder value through a balanced approach of reinvestment, strategic acquisitions, and capital returns.
Key Highlights
- 1Net earnings for the second quarter of 2007 were $311.2 million, a slight decrease from $314.5 million in the same period of 2006, but diluted EPS increased to $0.96 from $0.98, indicating improved profitability on a per-share basis.
- 2Consolidated sales increased by 13.5% to $2.67 billion in Q2 2007 compared to Q2 2006, with contributions from existing businesses (4.5% growth), acquisitions (6.5% growth), and favorable currency translation (2.5% growth).
- 3The Medical Technologies segment showed particularly strong growth, with sales up 38.0% year-over-year, driven by significant acquisition contributions.
- 4The company completed seven business acquisitions and the acquisition of remaining shares of Vision Systems Limited in the first six months of 2007, deploying $350 million in cash.
- 5Goodwill increased by $262 million in the first six months of 2007 due to acquisitions, totaling $6.88 billion at the end of the period.
- 6Long-term debt decreased to $2.13 billion from $2.42 billion at the end of 2006, reflecting a reduction in commercial paper borrowings.
- 7Danaher announced a definitive agreement to sell its power quality business for $280 million, expecting to report an after-tax gain of approximately $150 million ($0.46 per diluted share).